This study is testing if taking a single dose of azithromycin (an antibiotic) before starting labor induction can lower your risk of getting an infection during or after delivery. You might be able to join if you are 18-45 years old, in your third trimester (28 weeks or more pregnant) with a single baby, and planning to have your labor induced. Half of the participants will receive azithromycin, and the other half will receive a placebo (inactive pill). Researchers will compare infection rates at delivery and six weeks postpartum to see if azithromycin helps. The study aims to enroll 400 participants, but its current recruitment status is unclear.

Study design

This is a double-blinded, randomized controlled trial, meaning neither you nor your doctors will know if you receive azithromycin or a placebo. The study plans to include 400 participants.

What's involved

You would receive either azithromycin or a placebo pill before your labor induction begins.

Compensation

Not stated in the trial record.

Follow-up

Your infection status will be checked at delivery and again six weeks after you give birth.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.